Potomac, MD, United States of America

David Goldman

This inventor holds 6 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1985-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Goldman. Retrieved from https://idiyas.com/inventor/david-goldman-onta1l2q

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 83.3

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 31(Granted Patents)


Location History:

  • Gaithersburg, MD (US) (1985)
  • Potomac, MD (US) (1996 - 2007)

Company Filing History:


Years Active: 1985-2007

Loading Chart...
6 patents (USPTO):Explore Patents

Title: David Goldman: Innovator in Nucleic Acid Detection

Introduction

David Goldman, an accomplished inventor based in Potomac, Maryland, holds an impressive portfolio of six patents. His innovative work primarily focuses on methods for detecting nucleic acid sequence variations, contributing significantly to advancements in genetic research and diagnostics.

Latest Patents

Goldman's latest patents showcase his expertise in the field of genetics. One noteworthy patent describes methods for detecting nucleic acid sequence variation, where differences in melting profiles of multiple nucleic acids are analyzed. This technique allows for the identification of changes in wild-type nucleic acid sequences, such as single-nucleotide polymorphisms (SNPs) and small insertions or deletions.

Additionally, another patent details polynucleotides encoding a polymorphic human GABAA receptor alpha-6 subunit. This discovery highlights a polymorphism where a serine residue replaces a proline residue at amino acid position 385. This genetic variation is significant, as it is associated with decreased sensitivity to ethanol and benzodiazepine drugs, underscoring the clinical implications of Goldman's research.

Career Highlights

Throughout his career, Goldman has collaborated with esteemed organizations, notably representing the United States of America through the Department of Health and the Secretary of the Department of Health and Human Services. His contributions have been pivotal in translating complex genetic concepts into actionable medical insights.

Collaborations

Collaboration has been a cornerstone of Goldman's work, as he has partnered with notable colleagues such as Markku I Linnoila and Matti Virkkunen. These collaborations have fostered an environment of innovation, leading to the development of valuable knowledge and technologies in the field of genetic research.

Conclusion

David Goldman exemplifies the spirit of innovation through his contributions to the detection of nucleic acid sequence variations and the understanding of genetic polymorphisms. His patents not only reflect his ingenuity as an inventor but also underscore the potential impact of his work on healthcare and medicine. As the field continues to evolve, Goldman's research will undoubtedly play a significant role in shaping future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…